会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SYSTEMS AND METHODS FOR DETERMING INTRAOCULAR LENS POWER
    • 确定眼内镜片能量的系统和方法
    • WO2010064150A2
    • 2010-06-10
    • PCT/IB2009/008074
    • 2009-04-06
    • AMO REGIONAL HOLDINGSNORRBY, SverkerBERGMAN, Rolf
    • NORRBY, SverkerBERGMAN, Rolf
    • A61F2/16A61B3/10
    • A61F2/1613A61B3/0025A61B3/103A61B3/107
    • A system for providing an intraocular lens includes a processor and a computer readable memory. The computer readable memory is configured to communicate with the processor, the memory having stored therein at least one of: one or more ocular dimensions, and at least one predetermined refractive outcome. The memory further includes a sequence of instructions which, when executed by the processor, cause the processor to select an intraocular lens, select a power of an intraocular lens, or provide an intraocular lens. The sequence of instructions includes determining one or more dimensions of an eye. The instructions also include calculating, based on a mathematical relationship, a distance from an apex of a cornea of the eye to an apex or plane of the intraocular lens after insertion into the eye. The instructions further calculating an optical power of the intraocular lens suitable for providing a predetermined refractive outcome. The mathematical relationship includes an axial length of the eye, an anterior chamber depth of the natural crystalline lens, and a corneal radius of the eye, but is independent of a thickness of the natural crystalline lens.
    • 用于提供人工晶状体的系统包括处理器和计算机可读存储器。 计算机可读存储器被配置为与处理器通信,存储器中存储有以下中的至少一个:一个或多个眼部尺寸以及至少一个预定的屈光结果。 存储器还包括一系列指令,所述指令序列在由处理器执行时使处理器选择眼内透镜,选择眼内透镜的光焦度或提供眼内透镜。 指令序列包括确定眼睛的一个或多个维度。 该说明书还包括基于数学关系计算在插入眼中之后从眼角膜的顶点到眼内晶状体的顶点或平面的距离。 该指令进一步计算适合于提供预定屈光结果的眼内透镜的光焦度。 数学关系包括眼睛的轴向长度,自然晶状体的前房深度和眼睛的角膜半径,但与天然晶状体的厚度无关。
    • 3. 发明申请
    • KIT AND METHOD IN EYE SURGERY
    • 眼科手术中的包装和方法
    • WO2003096875A2
    • 2003-11-27
    • PCT/SE2003/000794
    • 2003-05-16
    • PHARMACIA GRONINGEN BVNORRBY, SverkerBERGMAN, RolfHILLBORN, Jöns
    • NORRBY, SverkerBERGMAN, RolfHILLBORN, Jöns
    • A61B
    • A61F2/1616A61F9/00736A61L31/044A61L31/046C09J189/00
    • A kit is provided, which comprises a) a collagen patch and b) an adhesive composition comprising (i) fibrin, fibrinogen or a combination thereof, and (ii) a biocompatible polymer capable of forming a viscous aqueous solution. Also provided is use of the kit for the preparation of a sealing device for use in ophthalmic surgery to replace a natural lens which has been removed, in which sealing device the collagen patch of the kit is adapted to seal an opening in a capsular bag of an eye while admitting the entrance of an injection device through the opening for injection of a lens-forming material into the capsule; and in which sealing device the adhesive composition of the kit is adapted to be applied to the collagen patch so as to enable adhesion of the collagen patch to the capsular bag. Also provided are methods for sealing an opening in a capsular bag of an eye, in which methods the kit is employed.
    • 提供了一种试剂盒,其包括a)胶原蛋白片和b)包含(i)纤维蛋白,纤维蛋白原或其组合的粘合剂组合物,和(ii)能够形成粘性水溶液的生物相容性聚合物。 还提供了该套件的用途,用于制备用于眼科手术中的密封装置,以取代已经去除的天然晶状体,其中,所述套件的胶原贴片适合于密封胶囊袋中的开口的密封装置 眼睛同时通过用于将透镜形成材料注射到胶囊中的开口进入注射装置; 并且其中将所述试剂盒的粘合剂组合物适用于所述胶原蛋白贴片的密封装置,以便能够将所述胶原蛋白贴片粘附到所述胶囊袋上。 还提供了用于密封眼睛囊袋中的开口的方法,其中采用该试剂盒的方法。
    • 10. 发明申请
    • COMPOSITIONS FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION AND THE USE THEREOF
    • 用于预防前列腺囊肿的组合物及其用途
    • WO2004030653A1
    • 2004-04-15
    • PCT/SE2003/001504
    • 2003-09-29
    • PHARMACIA GRONINGEN BVNORRBY, Sverker
    • NORRBY, Sverker
    • A61K9/08
    • A61K31/00A61K9/0048A61L27/54A61L2300/252A61L2300/258A61L2300/416A61L2300/432
    • The present invention relates to a composition comprising a sterile ophthalmic composition, which comprises one or more agents capable of inhibiting lens epithelial proliferation (e.g. fluorouracil, saporin, mitomycin or doxorubicin), dissolved in a physiologically isotonic solution. The present invention also relates to a method of preventing capsular opacification by using said composition. The method comprises the steps of : creating an incision within an eye and a capsulorhexis in a capsular bag of said eye; inserting at least a portion of cannula in said capsulorhexis; separating the natural crystalline lens from the capsular bag by injecting through a cannula the composition in a manner that generates a space between the capsular bag and the natural crystalline lens; retaining the composition in said space between the capsule and the natural crystalline lens for a sufficient time for said composition to effectively kill or render non-proliferative lens epithelial cells in or adjacent to said space; removing the lens and said composition; inserting an implant into the capsular bag.
    • 本发明涉及包含无菌眼用组合物的组合物,其包含一种或多种溶解于生理学等渗溶液中的能够抑制晶状体上皮增生的试剂(例如氟尿嘧啶,皂体蛋白,丝裂霉素或多柔比星)。 本发明还涉及通过使用所述组合物来防止荚膜混浊的方法。 该方法包括以下步骤:在眼睛的囊袋内产生眼内的切口和撕囊; 将插管的至少一部分插入所述撕囊术中; 通过套管注射组合物以在囊袋和天然晶状体之间产生空间的方式将天然晶状体与囊袋分开; 将组合物保持在胶囊和天然晶状体之间的所述空间中足够的时间,以使所述组合物在所述空间中或附近有效地杀死或使非增殖性晶状体上皮细胞发生; 去除镜片和所述组合物; 将植入物插入囊袋中。